Endorsement furthers Khiron's patient-focused approach to medical cannabis research and product development TORONTO, Dec. 11, 2018 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: ...
Former DEA Chief of Pharmaceutical Investigations leading Khiron's best-in-class procedures to self-regulate on diversion control TORONTO, June 19, 2018 /CNW/ - Khiron Life Sciences Corp. (TSXV: KHRN) ...
Toronto, Ontario--(Newsfile Corp. - April 20, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (FSE: A2JMZC) ("Khiron" or the "Company"), today announces the completion of its first ...
Equilibria named its first chief science officer, Dr. Jacqueline Jacques, a wellness industry veteran who will help the leadership team drive product development beyond hemp and design holistic ...
Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization or in this case loss) and Gross Profit do not have a standardized meaning prescribed by IFRS and are therefore unlikely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results